GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actuate Therapeutics Inc (NAS:ACTU) » Definitions » PB Ratio

ACTU (Actuate Therapeutics) PB Ratio : 1,524.00 (As of Mar. 26, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Actuate Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-26), Actuate Therapeutics's share price is $7.62. Actuate Therapeutics's Book Value per Share for the quarter that ended in Dec. 2024 was $0.01. Hence, Actuate Therapeutics's PB Ratio of today is 1,524.00.

The historical rank and industry rank for Actuate Therapeutics's PB Ratio or its related term are showing as below:

ACTU' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1543.58
Current: 762

During the past 3 years, Actuate Therapeutics's highest PB Ratio was 1543.58. The lowest was 0.00. And the median was 0.00.

ACTU's PB Ratio is ranked worse than
100% of 1282 companies
in the Biotechnology industry
Industry Median: 2.43 vs ACTU: 762.00

Back to Basics: PB Ratio


Actuate Therapeutics PB Ratio Historical Data

The historical data trend for Actuate Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actuate Therapeutics PB Ratio Chart

Actuate Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
PB Ratio
- - 1,592.00

Actuate Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only - - - 27.19 1,592.00

Competitive Comparison of Actuate Therapeutics's PB Ratio

For the Biotechnology subindustry, Actuate Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actuate Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actuate Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Actuate Therapeutics's PB Ratio falls into.



Actuate Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Actuate Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=7.62/0.005
=1,524.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Actuate Therapeutics  (NAS:ACTU) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Actuate Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Actuate Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Actuate Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
1751 River Run, Suite 400, Fort Worth, TX, USA, 76107
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.